WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2011139513) COMPOUNDS FOR THE TREATMENT OF HEPATITIS C
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2011/139513    International Application No.:    PCT/US2011/032457
Publication Date: 10.11.2011 International Filing Date: 14.04.2011
IPC:
C07D 498/06 (2006.01), A61K 31/53 (2006.01), A61P 31/14 (2006.01)
Applicants: BRISTOL-MYERS SQUIBB COMPANY [US/US]; Route 206 and Province Line Road Princeton, New Jersey 08543-4000 (US) (For All Designated States Except US).
WANG, Tao [US/US]; (US) (For US Only).
YIN, Zhiwei [US/US]; (US) (For US Only).
ZHANG, Zhongxing [CN/US]; (US) (For US Only).
PENDRI, Annapurna [US/US]; (US) (For US Only).
LI, Guo [CN/US]; (US) (For US Only).
GERRITZ, Samuel [US/US]; (US) (For US Only).
ZHAI, Weixu [US/US]; (US) (For US Only).
SCOLA, Paul Michael [US/US]; (US) (For US Only).
SUN, Li-Qiang [US/US]; (US) (For US Only).
MULL, Eric [US/US]; (US) (For US Only)
Inventors: WANG, Tao; (US).
YIN, Zhiwei; (US).
ZHANG, Zhongxing; (US).
PENDRI, Annapurna; (US).
LI, Guo; (US).
GERRITZ, Samuel; (US).
ZHAI, Weixu; (US).
SCOLA, Paul Michael; (US).
SUN, Li-Qiang; (US).
MULL, Eric; (US)
Agent: EPPERSON, James; Bristol-Myers Squibb Company P.O. Box 4000 Princeton, New Jersey 08543-4000 (US)
Priority Data:
61/331,037 04.05.2010 US
13/086,704 14.04.2011 US
Title (EN) COMPOUNDS FOR THE TREATMENT OF HEPATITIS C
(FR) COMPOSÉS DESTINÉS AU TRAITEMENT DE L'HÉPATITE C
Abstract: front page image
(EN)The disclosure provides compounds of formula I, including pharmaceutically acceptable salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV. [INSERT CHEMICAL STRUCTURE HERE] I
(FR)La présente invention concerne des composés de formule (I), y compris leurs sels de qualité pharmaceutique, des préparations, ainsi que des compositions et des méthodes d'emploi desdits composés. Les composés sont actifs vis-à-vis du virus de l'hépatite C (VHC) et peuvent être employés dans le traitement de patients infectés par le VHC. [INSÉRER STRUCTURE CHIMIQUE ICI] I
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)